BIT
ATRS

BlackRock Institutional Trust’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Institutional Trust’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6.57M Hold
2,820,119
– – ﹤0.01% 2624
2016
Q3 		$4.74M Hold
2,820,119
– – ﹤0.01% 2715
2016
Q2 		$2.96M Sell
2,820,119
-1,282,202
-31% -$1.24M ﹤0.01% 2894
2016
Q1 		$3.57M Sell
4,102,321
-29,512
-0.7% -$28.6K ﹤0.01% 2810
2015
Q4 		$5M Sell
4,131,833
-37,258
-0.9% -$51.9K ﹤0.01% 2726
2015
Q3 		$7.09M Buy
4,169,091
+64,454
+2% +$126K ﹤0.01% 2517
2015
Q2 		$8.54M Buy
4,104,637
+133,219
+3% +$323K ﹤0.01% 2508
2015
Q1 		$10.8M Sell
3,971,418
-3,191
-0.1% -$8.1K ﹤0.01% 2353
2014
Q4 		$10.2M Sell
3,974,609
-99,749
-2% -$224K ﹤0.01% 2352
2014
Q3 		$7.46M Buy
4,074,358
+81,531
+2% +$178K ﹤0.01% 2488
2014
Q2 		$10.7M Sell
3,992,827
-68,958
-2% -$208K ﹤0.01% 2401
2014
Q1 		$14.2M Buy
4,061,785
+263,004
+7% +$1.17M ﹤0.01% 2195
2013
Q4 		$17M Buy
3,798,781
+99,572
+3% +$406K ﹤0.01% 2068
2013
Q3 		$15M Buy
3,699,209
+230,510
+7% +$1.01M ﹤0.01% 2067
2013
Q2 		$14.4M Buy
+3,468,699
New +$13.4M ﹤0.01% 2050

Other funds holding ATRS

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Institutional Trust's ATRS Position: Q4 2016 in Review

BlackRock Institutional Trust held its Antares Pharma, Inc. (ATRS) position steady in Q4 2016 at 2,820,119 shares worth $6.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

BlackRock Institutional Trust first reported a position in ATRS in Q2 2013 and has held it in 15 quarters since. The position peaked at $17M in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q4 2016.

  • BlackRock Institutional Trust held 2,820,119 shares of Antares Pharma, Inc. worth $6.57M as of Q4 2016.
  • BlackRock Institutional Trust left its Antares Pharma, Inc. share count unchanged in Q4 2016.
  • Antares Pharma, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2624 holding.
  • BlackRock Institutional Trust first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Antares Pharma, Inc. position peaked at $17M in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.